These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 7878720)

  • 1. Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from São Paulo, Brazil.
    Ferreira Júnior OC; Vaz RS; Carvalho MB; Guerra C; Fabron AL; Rosemblit J; Hamerschlak N
    Transfusion; 1995 Mar; 35(3):258-63. PubMed ID: 7878720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study.
    Busch MP; Laycock M; Kleinman SH; Wages JW; Calabro M; Kaplan JE; Khabbaz RF; Hollingsworth CG
    Blood; 1994 Feb; 83(4):1143-8. PubMed ID: 8111054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selectivity of human T lymphotropic virus type-1 (HTLV-1) and HTLV-2 infection among different populations in Brazil.
    Gabbai AA; Bordin JO; Vieira-Filho JP; Kuroda A; Oliveira AS; Cruz MV; Ribeiro AA; Delaney SR; Henrard DR; Rosario J
    Am J Trop Med Hyg; 1993 Dec; 49(6):664-71. PubMed ID: 8279633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence, risk factors and genetic characterization of human T-cell lymphotropic virus types 1 and 2 in patients infected with human immunodeficiency virus type 1 in the cities of Ribeirão Preto and São Paulo].
    Kleine Neto W; Sanabani SS; Jamal LF; Sabino EC
    Rev Soc Bras Med Trop; 2009; 42(3):264-70. PubMed ID: 19684973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confirming the presence of HTLV-1 infection and the absence of HTLV-2 in blood donors from Arequipa, Peru.
    Quispe NC; Feria EB; Santos-Fortuna Ede L; Caterino-de-Araujo A
    Rev Inst Med Trop Sao Paulo; 2009; 51(1):25-9. PubMed ID: 19229387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of HTLV-1/2 infection and dermatological diseases in Manaus, State of Amazonas, Brazil.
    Passos LN; Moraes MP; Tamegão-Lopes B; Lemos JA; Machado PR; Mira MT; Talhari S
    Rev Soc Bras Med Trop; 2014 Jul; 47(4):507-9. PubMed ID: 25229293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the window period of human T-cell leukemia virus type 1 and 2 tests by a lookback study of seroconverters among Japanese voluntary blood donors.
    Sagara Y; Nakamura H; Yamamoto M; Ezaki T; Koga T; Shimamura M; Satake M; Irita K
    Transfusion; 2021 Feb; 61(2):484-493. PubMed ID: 33368334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of two enzyme-linked immunosorbent assay tests in relation to western blot in detecting human T-cell lymphotropic virus types I and II infection among HIV-1 infected patients from São Paulo, Brazil.
    Caterino-de-Araujo A; de los Santos-Fortuna E; Meleiro MC; Suleiman J; Calabrò ML; Favero A; De Rossi A; Chieco-Bianchi L
    Diagn Microbiol Infect Dis; 1998 Mar; 30(3):173-82. PubMed ID: 9572023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.
    Jacob F; Santos-Fortuna E; Azevedo RS; Caterino-de-Araujo A
    J Clin Virol; 2008 Jun; 42(2):149-55. PubMed ID: 18346935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1).
    Campos KR; Gonçalves MG; Costa NA; Caterino-de-Araujo A
    Braz J Infect Dis; 2017; 21(3):297-305. PubMed ID: 28343818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of HTLV-1/2 Among Voluntary Blood Donors in Vietnam.
    Pham D; Nguyen D; Nguyen TA; Tran C; Tran L; Devare S; Tran A; Bhatnagar S
    AIDS Res Hum Retroviruses; 2019 Apr; 35(4):376-381. PubMed ID: 30565470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of human T-lymphotropic virus type I and type II antibody among blood donors in Eastern Saudi Arabia.
    Ul-Hassan Z; Al-Bahrani AT; Panhotra BR
    Saudi Med J; 2004 Oct; 25(10):1419-22. PubMed ID: 15494814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
    Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T-lymphotropic virus (HTLV) types I and II infection in sexual contacts and family members of blood donors who are seropositive for HTLV type I or II. American Red Cross HTLV-I/II Collaborative Study Group.
    Sullivan MT; Williams AE; Fang CT; Notari EP; Poiesz BJ; Ehrlich GD
    Transfusion; 1993 Jul; 33(7):585-90. PubMed ID: 8333022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group.
    Kleinman SH; Kaplan JE; Khabbaz RF; Calabro MA; Thomson R; Busch M
    J Clin Microbiol; 1994 Mar; 32(3):603-7. PubMed ID: 8195365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of human retroviruses in blood samples from patients with hepatitis B and C in São Paulo, Brazil.
    Caterino-de-Araujo A; Campos KR; Petrucci TVB; Silva RXD; Lemos MF; Moreira RC
    Rev Soc Bras Med Trop; 2020; 53():e20190378. PubMed ID: 32049201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in prevalence and asymmetric distribution of human T cell lymphotropic virus 1 and 2 in blood donors, State of Minas Gerais, Brazil, 1993 to 2007.
    Dias-Bastos MR; Oliveira CD; Carneiro-Proietti AB
    Rev Soc Bras Med Trop; 2010; 43(6):615-9. PubMed ID: 21181009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/II-seropositive blood donors of the French West Indies.
    Wattel E; Mariotti M; Agis F; Gordien E; Prou O; Courouce AM; Rouger P; Wain-Hobson S; Chen IS; Lefrère JJ
    J Infect Dis; 1992 Feb; 165(2):369-72. PubMed ID: 1730903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1.
    Donegan E; Lee H; Operskalski EA; Shaw GM; Kleinman SH; Busch MP; Stevens CE; Schiff ER; Nowicki MJ; Hollingsworth CG
    Transfusion; 1994 Jun; 34(6):478-83. PubMed ID: 8023388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.